Type 2 Diabetes – Oral Treatment

Medical Condition: Type 2 Diabetes

Facility/Clinic: Accellacare

Age: 18 or older

Gender: Male/Female

Description: A research study is evaluating an investigational treatment called Semaglutide for the treatment of Type 2 Diabetes. This study will look at how well your blood sugar is controlled when you are taking of the three Semaglutide doses. This research study may be an option if you:

  • Have been diagnosed with Type 2 Diabetes for 180 days or longer
  • Have an HbA1c of 7.0 % or higher
  • Insulin naïve

Other criteria apply. Qualified participants will receive all study-related care and study medication at no cost.

Enrollment: Open

Patient Commitment Duration: Approximately 1 ½ years

Number of visits in study: Approximately 15 clinic visits and 2 phone calls

Patient Compensation: Financial compensation will be provided for time and travel expenses.

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-362-4040 between the hours of 8am-5pm for general research questions.